Clinical Trial Update: Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics

View source ↗

Summary

Completed clinical trial evaluating local susceptibility patterns of tigecycline in comparison to other antibiotics for infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Infection | Status: COMPLETED